Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Jones, Michelle R ^a   Chua, Angela ^a   Chen, Yii Der I ^a   Li, Xiaohui ^a   Krauss, Ronald M ^c   Rotter, Jerome I ^a,b   Legro, Richard S ^d   Azziz, Ricardo ^a,b   Goodarzi, Mark O ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PRASTERONE SULFATE; TESTOSTERONE; DKK1 PROTEIN, HUMAN; DNAJB1 PROTEIN, HUMAN; HEAT SHOCK PROTEIN 40; SIGNAL PEPTIDE;

ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DICKKOPF HOMOLOG 1 GENE; DIET RESTRICTION; DNAJB1 GENE; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; METABOLIC DISORDER; OVARY POLYCYSTIC DISEASE; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC DATABASE; GENETICS; METHODOLOGY; REPRODUCIBILITY;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; DATABASES, GENETIC; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HSP40 HEAT-SHOCK PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LINKAGE DISEQUILIBRIUM; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS;

EID: 79956136199     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020120     Document Type: Article

References (25)

1. Goodarzi MO, Azziz R, (2006) Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 20: 193-205.
2. Goodarzi MO, Erickson S, Port SC, Jennrich RI, Korenman SG, (2005) Beta-cell function: a key pathological determinant in polycystic ovary syndrome. J Clin Endocrinol Metab 90: 310-315.
3. Diamanti-Kandarakis E, Paterakis T, Kandarakis HA, (2006) Indices of low-grade inflammation in polycystic ovary syndrome. Ann N Y Acad Sci 1092: 175-186.
4. Wood JR, Nelson VL, Ho C, Jansen E, Wang CY, et al. (2003) The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem 278: 26380-26390.
5. Corton M, Botella-Carretero JI, Benguria A, Villuendas G, Zaballos A, et al. (2007) Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab 92: 328-337.
6. Borro M, Gentile G, Stigliano A, Misiti S, Toscano V, et al. (2007) Proteomic analysis of peripheral T lymphocytes, suitable circulating biosensors of strictly related diseases. Clin Exp Immunol 150: 494-501.
7. Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, et al. (2006) Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 25: 4116-4121.
8. Jansen E, Laven JS, Dommerholt HB, Polman J, van Rijt C, et al. (2004) Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Mol Endocrinol 18: 3050-3063.
9. Jee S, Hwang D, Seo S, Kim Y, Kim C, et al. (2007) Microarray analysis of insulin-regulated gene expression in the liver: the use of transgenic mice co-expressing insulin-siRNA and human IDE as an animal model. Int J Mol Med 20: 829-835.
10. Urbanek M, Legro RS, Driscoll DA, Azziz R, Erhmann D, et al. (1999) Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Science USA 96: 8573-8578.
11. Zawadzki J, Dunaif A, (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, editors. Polycystic Ovary Syndrome Boston Blackwell Scientific pp. 377-384.
12. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, et al. (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89: 2745-2749.
13. Legro RS, Driscoll D, Strauss JF, Fox J, Dunaif A, (1998) Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A 95: 14956-14960.
14. Simon JA, Lin F, Hulley SB, Blanche PJ, Waters D, et al. (2006) Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol 97: 843-850.
15. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
16. Jones MR, Italiano L, Wilson SG, Mullin BH, Mead R, et al. (2006) Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome. Fertil Steril 86: 1438-1446.
17. Ke L, Che YN, Cao YX, Wu XK, Hu YL, et al. (2010) Polymorphisms of the HSD17B6 and HSD17B5 genes in Chinese women with polycystic ovary syndrome. J Womens Health (Larchmt) 19: 2227-2232.
18. Jones MR, Mathur R, Cui J, Guo X, Azziz R, et al. (2009) Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene. J Clin Endocrinol Metab 94: 5034-5038.
19. Mohamed-Hussein ZA, Harun S, (2009) Construction of a polycystic ovarian syndrome (PCOS) pathway based on the interactions of PCOS-related proteins retrieved from bibliomic data. Theor Biol Med Model 6: 18.
20. Dakhova O, O'Day D, Kinet N, Yucer N, Wiese M, et al. (2009) Dickkopf-like1 regulates postpubertal spermatocyte apoptosis and testosterone production. Endocrinology 150: 404-412.
21. Kwack MH, Sung YK, Chung EJ, Im SU, Ahn JS, et al. (2008) Dihydrotestosterone-inducible dickkopf 1 from balding dermal papilla cells causes apoptosis in follicular keratinocytes. J Invest Dermatol 128: 262-269.
22. Piters E, Balemans W, Nielsen TL, Andersen M, Boudin E, et al. (2010) Common genetic variation in the DKK1 gene is associated with hip axis length but not with bone mineral density and bone turnover markers in young adult men: results from the Odense Androgen Study. Calcif Tissue Int 86: 271-281.
23. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H, (2007) Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92: 405-413.
24. Legro RS, Schlaff WD, Diamond MP, Coutifaris C, Casson PR, et al. (2010) Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab 95: 5305-5313.
25. Prescott J, Coetzee GA, (2006) Molecular chaperones throughout the life cycle of the androgen receptor. Cancer Lett 231: 12-19.